BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30473794)

  • 1. An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome.
    Endo S; Shimazaki R;
    J Intensive Care; 2018; 6():75. PubMed ID: 30473794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
    Kuroda H; Masuda Y
    Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
    Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
    Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
    Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation.
    Eguchi Y; Gando S; Ishikura H; Saitoh D; Mimuro J; Takahashi H; Kitajima I; Tsuji H; Matsushita T; Tsujita R; Nagao O; Sakata Y
    J Intensive Care; 2014; 2(1):30. PubMed ID: 25520842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.
    Iba T; Di Nisio M; Thachil J; Wada H; Asakura H; Sato K; Kitamura N; Saitoh D
    Crit Care; 2016 Sep; 20():287. PubMed ID: 27629997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation.
    Iba T; Arakawa M; Mochizuki K; Nishida O; Wada H; Levy JH
    Clin Appl Thromb Hemost; 2019; 25():1076029618824044. PubMed ID: 30808223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
    Iba T; Saitoh D; Wada H; Asakura H
    Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of antithrombin III supplementation in an overt disseminated intravascular coagulation: a longitudinal single-institutional experience and retrospective analysis.
    Lee S; Kim J; Ji M; Moon H; Lee W
    Ann Palliat Med; 2024 May; 13(3):477-495. PubMed ID: 38735696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis.
    Gando S; Saitoh D; Ogura H; Fujishima S; Mayumi T; Araki T; Ikeda H; Kotani J; Kushimoto S; Miki Y; Shiraishi S; Suzuki K; Suzuki Y; Takeyama N; Takuma K; Tsuruta R; Yamaguchi Y; Yamashita N; Aikawa N;
    Crit Care; 2013 Jun; 17(3):R111. PubMed ID: 23787004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin.
    Iba T; Arakawa M; Levy JH; Yamakawa K; Koami H; Hifumi T; Sato K
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1020-1026. PubMed ID: 29695178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the simplified JSTH score criteria in the early diagnosis of sepsis-associated disseminated intravascular coagulation].
    Wang YY; Wan XH; Huang QQ; Wang G; Wan LJ; Liu OY
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):837-841. PubMed ID: 32234155
    [No Abstract]   [Full Text] [Related]  

  • 15. Proposal and Validation of a Clinically Relevant Modification of the Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Diagnostic Criteria for Sepsis.
    Yamakawa K; Umemura Y; Mochizuki K; Matsuoka T; Wada T; Hayakawa M; Iba T; Ohtomo Y; Okamoto K; Mayumi T; Ikeda T; Ishikura H; Ogura H; Kushimoto S; Saitoh D; Gando S
    Thromb Haemost; 2024 May; ():. PubMed ID: 38729189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yamakawa K; Ogura H; Fujimi S; Morikawa M; Ogawa Y; Mohri T; Nakamori Y; Inoue Y; Kuwagata Y; Tanaka H; Hamasaki T; Shimazu T
    Intensive Care Med; 2013 Apr; 39(4):644-52. PubMed ID: 23361628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.
    Nagafuchi H; Eguchi Y; Ikeda T
    Clin Appl Thromb Hemost; 2019; 25():1076029619834350. PubMed ID: 30836769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients].
    Xu Y; Zhu R; Sun Y; Li X; Ma X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):127-132. PubMed ID: 28625259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems.
    Saito S; Uchino S; Hayakawa M; Yamakawa K; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Sasabuchi Y;
    J Crit Care; 2019 Apr; 50():23-30. PubMed ID: 30471557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.
    Gando S; Iba T; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Murata A; Ikeda T; Ishikura H; Ueyama M; Ogura H; Kushimoto S; Saitoh D; Endo S; Shimazaki S;
    Crit Care Med; 2006 Mar; 34(3):625-31. PubMed ID: 16521260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.